Resveratrol Upregulated SIRT1, FOXO1, and Adiponectin and Downregulated PPARγ1–3 mRNA Expression in Human Visceral Adipocytes

Resveratrol: A multitargeted agent for age-associated chronic diseases

(2011) Kuzhuvelil B. Harikumar et al.   CELL CYCLE

Sirtuin activators

(2009) Francisco J Alcaín et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY

Adiponectin and alcoholic fatty liver disease

(2008) Christopher Q. Rogers et al.   IUBMB LIFE

Porcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol1

(2008) T. Shan et al.   JOURNAL OF ANIMAL SCIENCE

Obesity-Associated Liver Disease

(2008) Giulio Marchesini et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease

(2008) Hong Ma et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Modulation of peroxisome proliferator–activated receptor γ stability and transcriptional activity in adipocytes by resveratrol

(2008) Z. Elizabeth Floyd et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

SIRT2 Suppresses Adipocyte Differentiation by Deacetylating FOXO1 and Enhancing FOXO1's Repressive Interaction with PPARγ

(2008) Fei Wang et al.   MOLECULAR BIOLOGY OF THE CELL

The role of FoxO in the regulation of metabolism

(2008) D N Gross et al.   ONCOGENE

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

(2008) Srujana Rayalam et al.   PHYTOTHERAPY RESEARCH